Bob Rogers brings to Apixio two decades of algorithm development and marketing experience. As Chief Scientist, Bob is responsible for strategic direction and development of the algorithms at the core of Apixio's applications. He is also Apixio's liaison to the medical and academic communities. Bob is the founder of Counterpart Consulting, a consulting firm specializing in advanced analytics for hedge fund and medical applications. Prior to Counterpart Consulting, Bob was Senior Product Manager at Carl Zeiss Meditec where he was responsible for the complete product lifecycle of the most commonly deployed diagnostic device in ophthalmology. Previously, Bob was founder and President of Tri-Valley Capital, a hedge fund, and co-founder and VP of R&D at Arjewel Inc, a private fund, that generated returns based on proprietary algorithms he developed. Bob has also spent several years as an academic researcher, has published a number of academic papers in astrophysics and artificial neural networks and is co-author of the book, "Artificial Neural Networks: Forecasting Time Series." Bob received his undergraduate degree in physics from UC Berkeley and his PhD in physics from Harvard University.